Lipella Pharmaceuticals Inc.
LIPO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,016 | -$4,619 | -$2,598 | -$1,865 |
| Dep. & Amort. | $3 | $2 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $749 | $1,355 | $747 | $729 |
| Change in WC | $113 | -$9 | $10 | $198 |
| Other Non-Cash | $200 | $121 | $10 | -$50 |
| Operating Cash Flow | -$3,951 | -$3,150 | -$1,831 | -$989 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$14 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $300,546 | -$301 |
| Inv. Sales/Matur. | $0 | $0 | $301 | $0 |
| Other Inv. Act. | $0 | $0 | -$300,546 | $0 |
| Investing Cash Flow | $0 | -$14 | $301 | -$301 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$275 | $275 | $0 |
| Stock Issued | $0 | $0 | $4,964 | $2,097 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,842 | $1,612 | $0 | $0 |
| Financing Cash Flow | $2,842 | $1,337 | $5,239 | $2,097 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,109 | -$1,828 | $3,708 | $807 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,294 | $5,122 | $1,414 | $607 |
| End Cash | $2,185 | $3,294 | $5,122 | $1,414 |
| Free Cash Flow | -$3,951 | -$3,165 | -$1,831 | -$989 |